TIAA Trust, National Association’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,356
Closed -$361K 508
2025
Q4
$361K Sell
7,356
-297
-4% -$13.9K ﹤0.01% 544
2025
Q3
$330K Sell
7,653
-451
-6% -$17.6K ﹤0.01% 563
2025
Q2
$311K Buy
8,104
+915
+13% +$35K ﹤0.01% 548
2025
Q1
$279K Sell
7,189
-547
-7% -$20K ﹤0.01% 553
2024
Q4
$262K Sell
7,736
-319
-4% -$11.5K ﹤0.01% 567
2024
Q3
$329K Buy
8,055
+231
+3% +$9.45K ﹤0.01% 518
2024
Q2
$301K Buy
7,824
+788
+11% +$33.1K ﹤0.01% 516
2024
Q1
$302K Buy
+7,036
New +$290K ﹤0.01% 516

Other funds holding GSK

TIAA Trust, National Association's GSK Position: Q1 2026 in Review

TIAA Trust, National Association sold out of GSK (GSK) in Q1 2026, closing a stake of 7,356 shares — an estimated $361K sold.

TIAA Trust, National Association first reported a position in GSK in Q1 2024 and held it in 8 quarters. The position peaked at $361K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • TIAA Trust, National Association reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 7,356 GSK shares in Q1 2026, an estimated $361K.
  • TIAA Trust, National Association first reported a position in GSK in Q1 2024 and held it in 8 quarters.
  • TIAA Trust, National Association's GSK position peaked at $361K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.